LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Erlotinib | 10 | uM | LJP5 | 2 | M19 | 72 | hr | 658 | 2489 | 3953 | 0.6295 | 0.6724 |
Hs 578T | Erlotinib | 10 | uM | LJP5 | 3 | M19 | 72 | hr | 658 | 2389 | 3938 | 0.6066 | 0.6478 |
Hs 578T | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 658 | 3646 | 3705 | 0.9839 | 0.9870 |
Hs 578T | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 658 | 3980 | 3807 | 1.0453 | 1.0353 |
Hs 578T | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 658 | 3704 | 3769 | 0.9826 | 0.9861 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 658 | 3671 | 3705 | 0.9906 | 0.9924 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 658 | 3694 | 3807 | 0.9702 | 0.9762 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 658 | 3701 | 3769 | 0.9818 | 0.9854 |
Hs 578T | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 658 | 3753 | 3705 | 1.0127 | 1.0102 |
Hs 578T | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 658 | 3736 | 3807 | 0.9812 | 0.9851 |
Hs 578T | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 658 | 3820 | 3769 | 1.0133 | 1.0106 |
Hs 578T | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 658 | 3690 | 3705 | 0.9957 | 0.9966 |
Hs 578T | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 658 | 3753 | 3807 | 0.9857 | 0.9886 |
Hs 578T | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 658 | 3781 | 3769 | 1.0030 | 1.0024 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 658 | 3673 | 3705 | 0.9911 | 0.9929 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 658 | 3750 | 3807 | 0.9849 | 0.9880 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 658 | 3706 | 3769 | 0.9831 | 0.9865 |
Hs 578T | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 658 | 3097 | 3705 | 0.8357 | 0.8611 |
Hs 578T | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 658 | 3240 | 3807 | 0.8509 | 0.8765 |
Hs 578T | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 658 | 3034 | 3769 | 0.8048 | 0.8348 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 658 | 4126 | 3908 | 1.0556 | 1.0426 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 658 | 3952 | 3953 | 0.9996 | 0.9997 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 658 | 4149 | 3938 | 1.0535 | 1.0408 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 658 | 3856 | 3908 | 0.9866 | 0.9895 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 2 | N17 | 72 | hr | 658 | 4047 | 3953 | 1.0236 | 1.0181 |